SECUKINUMAB
secukinumab 150 mg/mL injection, 1 mL pen device
SECUKINUMAB (12321L)
12321L
Manner of administration:Injection
Restriction
Indication: Non-radiographic axial spondyloarthritis
Treatment phase: Initial treatment - Initial 1 (New patient)
Restriction
Indication: Non-radiographic axial spondyloarthritis
Treatment phase: Initial treatment - Initial 2 (Change or recommencement of treatment after a break
in biological medicine of less than 5 years)
Restriction
Indication: Non-radiographic axial spondyloarthritis
Treatment phase: Initial treatment - Initial 3 (Recommencement of treatment after a break in biological
medicine of more than 5 years)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 5 | Max qty units: 5 | # of repeats: 0 | DPMQ: $3,289.78 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Cosentyx | |||||